LOS ANGELES--(BUSINESS WIRE)--Pearl, the leader in AI solutions for efficiency, accuracy, and consistency in dental care, today announced that it has received clearance from the United Arab Emirates’ (UAE) Ministry of Health and Prevention for Second Opinion®, the first comprehensive AI-powered real-time pathology detection aid for dentists. The latest clearance follows the solution’s recent CE-marking in Europe, Medical Device Establishment License (MDEL) for use in Canada, and TGA/MEDSAFE clearance in Australia and New Zealand. Second Opinion helps dentists by automatically scanning and detecting a broad range of dental conditions via x-ray and meets stringent patient and user safety standards.
“With Second Opinion cleared, patients in the UAE can begin to gain the many benefits of AI-assisted dentistry and greater assurance in quality of care at Second Opinion-equipped dental practices,” said Dr. Oussama Alaoui, Head of Prosthodontics at Harmony Medical Center in Abu Dhabi, “I look forward to witnessing the revolutionary impact and advantages that AI will bring to our dental care.”
Second Opinion applies computer vision technologies to detect a comprehensive array of pathologies, existing restorations and natural anatomy in dental radiographs. The system analyzes radiographs in real time, allowing dentists to display, review, add or reject the system’s detections while conducting exams.
“Our Second Opinion technology enables more efficient and transparent doctor-patient communication while facilitating a higher standard of care,” said Ophir Tanz, CEO and founder of Pearl. “With the implementation of the platform in the UAE, we are excited to take a first step toward driving growth and better patient outcomes across Middle Eastern dentistry.”
Dentists in UAE and other approved countries can begin using Pearl’s Second Opinion today by visiting www.hellopearl.com/products/second-opinion.
About Pearl
Pearl is shaping the future of dental care by delivering AI and computer vision solutions that advance efficiency, accuracy, transparency and patient care. Founded in 2019 by Ophir Tanz, Pearl is backed by Craft Ventures and other leading venture capital firms. For more information or to request a demonstration, please visit https://www.hellopearl.com.
